• Return to Headlines

Chemocentryx Inc: 52-Week High Recently Eclipsed (CCXI)

By David Diaz

Chemocentryx Inc (NASDAQ:CCXI) traded today at a new 52-week high of $13.57. Approximately 166,000 shares have changed hands today, as compared to an average 30-day volume of 227,000 shares.

ChemoCentryx, Inc. is a biopharmaceutical company. The Company researches orally-administered small-molecule therapies for inflammatory diseases.

Over the past year, Chemocentryx Inc has traded in a range of $3.95 to $13.57 and is now at $13.45, 241% above that low. The 200-day and 50-day moving averages have moved 2.41% lower and 3.68% lower over the past week, respectively.

There is potential upside of 19.0% for shares of Chemocentryx Inc based on a current price of $13.45 and an average consensus analyst price target of $16.00. The stock should find initial support at its 200-day moving average (MA) of $5.41 and further support at its 50-day MA of $2.75.

SmarTrend recommended that subscribers consider buying shares of Chemocentryx Inc on January 4th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $8.50. Since that recommendation, shares of Chemocentryx Inc have risen 50.5%. We continue to monitor CCXI for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows chemocentryx inc

Ticker(s): CCXI